EUVIMEDEUVIMED entdecken
Crossref

Impact of Rheumatoid Arthritis and Seropositivity on the Risk of Non-Cystic Fibrosis Bronchiectasis

Hayoung Choi, Kyungdo Han, Jin Hyung Jung, Junhee Park, Bo-Guen Kim, Bumhee Yang, Yeonghee Eun, Hyungjin Kim, Dong Wook Shin, Hyun Lee

CHEST · 2024-06 · 165 (6) · 1330-1340

DOI: 10.1016/j.chest.2024.01.001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CHEST, 2024-06. Verfasst von Hayoung Choi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Hallym University Kangnam Sacred Heart Hospital, Hallym …. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Bronchiectasis. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Korea Ministry of Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Despite the coexistence of bronchiectasis and rheumatoid arthritis (RA) and the poor prognosis associated with the combination of conditions, to our knowledge, no longitudinal studies that comprehensively evaluated whether patients with RA have a higher risk of bronchiectasis compared with those without RA have been published. Whether seropositivity is associated with an increased risk of bronchiectasis in RA is the subject of ongoing controversy. RESEARCH QUESTION: Does RA influence the development of bronchiectasis? Is seropositivity associated with an increased risk of bronchiectasis in RA? STUDY DESIGN AND METHODS: The incidence of bronchiectasis was compared between individuals with RA (n = 50,651; seropositive rheumatoid arthritis [SPRA]: n = 35,879 and seronegative rheumatoid arthritis [SNRA]: n = 14,772) and 1:5 age- and sex-matched control patients (n = 253,255) enrolled between 2010 and 2017 in the Korean National Health Insurance Service database. The participants were followed from 1 year after RA diagnosis or the corresponding index date to the date of bronchiectasis incidence, censored date, or December 2019. RESULTS: The cumulative incidence of bronchiectasis at 9 years of follow-up was approximately 7% in participants with RA. During a median follow-up of 4.3 years (interquartile range, 2.6-6.3 years), participants with RA showed a 2.12-fold higher risk of developing bronchiectasis than matched control participants, even after adjusting for potential confounders related to bronchiectasis development (95% CI, 2.00-2.25). In an analysis of RA serologic status using a fully adjusted model, participants with SPRA and those with SNRA showed 2.34-fold (95% CI, 2.20-2.49) and 1.56-fold (95% CI, 1.40-1.73) increased risks, respectively, compared with matched control participants. INTERPRETATION: Individuals with RA had approximately twice the risk of developing bronchiectasis than matched control individuals, even after adjusting for potential confounders. The increased risk was more evident in individuals with SPRA than in those with SNRA, implying that rheumatic inflammation plays a major role in the development of RA-bronchiectasis overlap.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidBronchiectasisHumansMaleFemaleMiddle AgedIncidenceRepublic of KoreaRisk FactorsAgedAdultCase-Control Studies

Stichwörter der Autor:innen

bronchiectasisepidemiologyinflammationrheumatoid arthritis

Autor:innen und Institutionen

  • Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Hallym University Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Republic of Korea.
  • Department of Statistics and Actuarial Science, Soongsil University, Seoul, Republic of Korea.
  • Department of Biostatistics, College of Medicine, Catholic University of Korea, Seoul, Republic of Korea.
  • Department of Family Medicine/Supportive Care Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Division of Pulmonary Medicine and Allergy, Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Republic of Korea.
  • Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju, Republic of Korea.

Förderung

  • Korea Ministry of Education

Zitieren

APA

Choi, H., Han, K., Jung, J. H., Park, J., Kim, B. G., Yang, B., Eun, Y., Kim, H., Shin, D. W., & Lee, H. (2024). Impact of Rheumatoid Arthritis and Seropositivity on the Risk of Non-Cystic Fibrosis Bronchiectasis. CHEST, 165(6), 1330-1340. https://doi.org/10.1016/j.chest.2024.01.001

Vancouver

Choi H, Han K, Jung JH, Park J, Kim BG, Yang B, et al. Impact of Rheumatoid Arthritis and Seropositivity on the Risk of Non-Cystic Fibrosis Bronchiectasis. CHEST. 2024;165(6):1330-1340. doi:10.1016/j.chest.2024.01.001

BibTeX
@article{Choi2024,
  author = {Choi, Hayoung and Han, Kyungdo and Jung, Jin Hyung and Park, Junhee and Kim, Bo-Guen and Yang, Bumhee and Eun, Yeonghee and Kim, Hyungjin and Shin, Dong Wook and Lee, Hyun},
  title = {Impact of Rheumatoid Arthritis and Seropositivity on the Risk of Non-Cystic Fibrosis Bronchiectasis},
  journal = {CHEST},
  year = {2024},
  volume = {165},
  number = {6},
  pages = {1330--1340},
  doi = {10.1016/j.chest.2024.01.001}
}
Kostenlos starten →